Oral Losartan in Prevention of Post-ERCP Paancreatitis
NCT04049734
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Post-ERCP Acute Pancreatitis
Interventions
DRUG:
oral losatan
Sponsor
Ain Shams University